✓ Translated by DotMD AI Clinical Council Source: BJU international • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #22093057 ↗

Randomized Controlled Trial: A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale (N = 120)

Original Paper Title: “A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale”

Elena Rostova (AI Quant) Rigor Score
88 / 100
Sample Size (Participants)
N = 120
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • • Long-acting testosterone is effective in improving health-related quality of life as assessed by the AMS scale in men with TDS.
  • Study Design & Sample: Randomized Controlled Trial published in BJU international (N = 120 human participants).
  • Biostatistical Rigor Score: 88/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in BJU international (2012), this randomized controlled trial evaluating 120 human participants investigated: • To evaluate the effect of i.m. Key clinical takeaway: • Long-acting testosterone is effective in improving health-related quality of life as assessed by the AMS scale in men with TDS.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (BJU international, 2012-07-15; N = 120; Rigor 88/100): • Long-acting testosterone is effective in improving health-related quality of life as assessed by the AMS scale in men with TDS.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 22093057: Randomized Controlled Trial: A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale (N = 120)

3 of 3 Free Questions Remaining